Subramanian, J., Katta, A., Masood, A., Vudem, D. R., & Kancha, R. K. (2019). Emergence of ERBB2 Mutation as a Biomarker and an Actionable Target in Solid Cancers. Oncologist.
Chicago ZitierstilSubramanian, Janakiraman, Archana Katta, Ashiq Masood, Dashavantha Reddy Vudem, und Rama Krishna Kancha. "Emergence of ERBB2 Mutation As a Biomarker and an Actionable Target in Solid Cancers." Oncologist 2019.
MLA ZitierstilSubramanian, Janakiraman, et al. "Emergence of ERBB2 Mutation As a Biomarker and an Actionable Target in Solid Cancers." Oncologist 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.